Keyphrases
Anti-tumor Necrosis Factor (anti-TNF)
14%
Apoptosis
28%
Cellular Effects
14%
Chimeric Antibody
14%
Crohn's Disease
14%
Direct Activity
14%
Granulocyte Colony-stimulating Factor (G-CSF)
28%
Increased Vulnerability
14%
Inflammatory Bowel Disease
100%
Infliximab
100%
Intestinal Disorders
14%
Intestinal mucosa
14%
Mechanism of Action
100%
Mucosal Inflammation
14%
Mucosal T Cells
14%
Novel Pathways
14%
Novel Therapeutics
14%
T Cells
42%
Tumor Necrosis Factor-α
100%
Immunology and Microbiology
Chimeric Antibody
14%
Crohn's Disease
14%
Cytokine
14%
Downregulation
14%
Granulocyte Macrophage Colony-Stimulating Factor
28%
In Vitro
14%
Inflammatory Bowel Disease
100%
Infliximab
100%
Neutralization
100%
Programmed Cell Death
28%
Susceptibility
14%
T Cell
57%
Tumor Necrosis Factor
14%
Tumor Necrosis Factor Alpha
100%
Medicine and Dentistry
Chimeric Antibody
12%
Crohn's Disease
12%
Cytokine
12%
Downregulation
12%
Enteropathy
12%
Granulocyte Macrophage Colony Stimulating Factor
25%
In Vitro
12%
Inflammatory Bowel Disease
100%
Infliximab
100%
Neutralization
100%
Programmed Cell Death
25%
T Cell
50%
Tumor Necrosis Factor
100%
Neuroscience
Chimeric Antibody
14%
Cytokine
14%
Granulocyte Macrophage Colony-Stimulating Factor
28%
In Vitro
14%
In Vivo
14%
Inflammatory Bowel Disease
100%
Infliximab
100%
Programmed Cell Death
28%
T Cell
57%
Tumor Necrosis Factor Alpha
100%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antibody
12%
Crohn's Disease
12%
Cytokine
12%
Enteropathy
12%
Granulocyte Macrophage Colony Stimulating Factor
25%
Inflammation
12%
Inflammatory Bowel Disease
100%
Infliximab
100%
Tumor Necrosis Factor
100%